Date Title Description PDF
04 Nov 2022 On business and financial situation The Company releases the first nine months 2022 financial results presentation Download
15 Mar 2022 On significant placements in financial instruments Bestinver announces details of an accelerated book building process of approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A. Download
14 Mar 2022 On significant placements in financial instruments Bestinver announces the beginning of an accelerated book building process approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A. Download
23 Feb 2022 On business and financial situation The Company releases the press release related to the full year 2021 financial results Download
23 Feb 2022 On business and financial situation The Company releases the full year 2021 financial results presentation Download

Pages

Date Title Description PDF
20 Oct 2020 Announcement of general shareholders’ meeting ROVI releases the information related to its General Shareholders Meeting Download
15 Oct 2020 Announcement of general shareholders’ meeting   In view of the exceptional circumstances derived from the spread of Covid-19, the Company has agreed that the Ordinary General Meeting be held by exclusively telematic means.   Download
01 Oct 2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the third quarter of 2020 Download
11 Sep 2020 Announcement of general shareholders’ meeting Rovi releases the information related to its 2020 General Shareholders Meeting. Download
27 Jul 2020 On business and financial situation The company releases the press release related to the 2020 first half financial results Download

Pages

Date Title Description PDF
26 Feb 2019 Información sobre resultados ROVI releases the presentation related to the full year 2018 results Download
26 Feb 2019 Información sobre resultados ROVI releases the press release related to the full year 2018 results Download
15 Feb 2019 Others on business performance and financial information ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets Download
09 Jan 2019 Others on business performance and financial information ROVI informs about the adquisition of Falithrom® for the German market Download
08 Jan 2019 Liquidity contracts and specialists Liquidity contract: transactions conducted in the fourth quarter of 2018 Download

Pages